Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX

State Street Corp reported a 6.40% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 7, 2026

State Street Corp reported a 6.40% stake in Syndax Pharmaceuticals, Inc., 5,658,465 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).

Stake
6.40%
Shares
5,658,465
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
STATE STREET CORPORATION6.40%5,658,465

Source

View original at SEC

Related